Armistice Capital »

Biondvax Pharmaceuticals shares owned by Armistice Capital

Quarter-by-quarter ownership of Biondvax Pharmaceuticals (SCNI) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Biondvax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biondvax Pharmaceuticals held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biondvax Pharmaceuticals by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $315k 362k 0.87

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Biondvax Pharmaceuticals

Rhumbline Advisers
UBS Group
Main Street Group
Aspire Private Capital
Global Retirement Partners
Wells Fargo & Company
Royal Bank of Canada

View all funds holding Biondvax Pharmaceuticals